Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.1756 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.15583 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.15892 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.11614 | 7 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.09706 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.21937 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.20939 | 8 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.13042 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.11533 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.14074 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.13846 | 7 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.12584 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.15563 | 7 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.146 | 7 |